{"id":"https://openalex.org/W2020051786","doi":"https://doi.org/10.1186/1471-2369-13-95","title":"An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients","display_name":"An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients","publication_year":2012,"publication_date":"2012-08-30","ids":{"openalex":"https://openalex.org/W2020051786","doi":"https://doi.org/10.1186/1471-2369-13-95","mag":"2020051786","pmid":"https://pubmed.ncbi.nlm.nih.gov/22935486","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3511162"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2369-13-95","doi":"https://doi.org/10.1186/1471-2369-13-95","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2369-13-95","pdf_url":"https://bmcnephrol.biomedcentral.com/counter/pdf/10.1186/1471-2369-13-95","source":{"id":"https://openalex.org/S172421378","display_name":"BMC Nephrology","issn_l":"1471-2369","issn":["1471-2369"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcnephrol.biomedcentral.com/counter/pdf/10.1186/1471-2369-13-95","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073956335","display_name":"Anatole Besarab","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Anatole Besarab","raw_affiliation_strings":["Henry Ford Hospital, Detroit, MI, USA. abesara1@hfhs.org","Henry Ford Hospital - Detroit, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Hospital, Detroit, MI, USA. abesara1@hfhs.org","institution_ids":["https://openalex.org/I2803043754"]},{"raw_affiliation_string":"Henry Ford Hospital - Detroit, USA","institution_ids":["https://openalex.org/I2803043754"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089317996","display_name":"Steven Zeig","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven N Zeig","raw_affiliation_strings":["Pines Clinical Research, Pembroke Pines, FL, USA","Pines Clinical Research, Pembroke Pines, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pines Clinical Research, Pembroke Pines, FL, USA","institution_ids":[]},{"raw_affiliation_string":"Pines Clinical Research, Pembroke Pines, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111933832","display_name":"Edouard R. Martin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edouard R Martin","raw_affiliation_strings":["South Florida Nephrology Associates, Lauderdale Lakes, FL, USA","South Florida Nephrology Associates, Lauderdale Lakes, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Florida Nephrology Associates, Lauderdale Lakes, FL, USA","institution_ids":[]},{"raw_affiliation_string":"South Florida Nephrology Associates, Lauderdale Lakes, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046497650","display_name":"Pablo E. P\u00e9rgola","orcid":"https://orcid.org/0000-0002-5876-894X","observed_orcids":["https://orcid.org/0000-0002-5876-894X"]},"institutions":[{"id":"https://openalex.org/I4210157924","display_name":"Renal Associates P. A.","ror":"https://ror.org/04wc1v131","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210157924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pablo E Pergola","raw_affiliation_strings":["Renal Associates PA, San Antonio, TX, USA","Renal Associates PA, San Antonio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renal Associates PA, San Antonio, TX, USA","institution_ids":["https://openalex.org/I4210157924"]},{"raw_affiliation_string":"Renal Associates PA, San Antonio, USA","institution_ids":["https://openalex.org/I4210157924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111644528","display_name":"Frederick C. Whittier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederick C Whittier","raw_affiliation_strings":["Clinical Research Ltd, Canton, OH, USA","Clinical Research Ltd, Canton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Ltd, Canton, OH, USA","institution_ids":[]},{"raw_affiliation_string":"Clinical Research Ltd, Canton, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080419400","display_name":"Raja Issa Zabaneh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raja I Zabaneh","raw_affiliation_strings":["Northwest Louisiana Nephrology, Shreveport, LA, USA","Northwest Louisiana Nephrology, Shreveport, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwest Louisiana Nephrology, Shreveport, LA, USA","institution_ids":[]},{"raw_affiliation_string":"Northwest Louisiana Nephrology, Shreveport, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028659333","display_name":"Brigitte M. Schiller","orcid":"https://orcid.org/0000-0003-4705-9723","observed_orcids":["https://orcid.org/0000-0003-4705-9723"]},"institutions":[{"id":"https://openalex.org/I4210160057","display_name":"Satellite Healthcare (United States)","ror":"https://ror.org/054j4ex16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160057"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brigitte Schiller","raw_affiliation_strings":["Satellite Healthcare, San Jose, CA, USA","Satellite Healthcare, San Jose, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Satellite Healthcare, San Jose, CA, USA","institution_ids":["https://openalex.org/I4210160057"]},{"raw_affiliation_string":"Satellite Healthcare, San Jose, USA","institution_ids":["https://openalex.org/I4210160057"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108493061","display_name":"Martha R. Mayo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151439","display_name":"Affymax (United States)","ror":"https://ror.org/0505r1x13","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha Mayo","raw_affiliation_strings":["Affymax, Inc, Palo Alto, CA, USA","Affymax, Inc, Palo Alto, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affymax, Inc, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I4210151439"]},{"raw_affiliation_string":"Affymax, Inc, Palo Alto, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015175358","display_name":"Carol A. Francisco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151439","display_name":"Affymax (United States)","ror":"https://ror.org/0505r1x13","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol A Francisco","raw_affiliation_strings":["Affymax, Inc, Palo Alto, CA, USA","Affymax, Inc, Palo Alto, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affymax, Inc, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I4210151439"]},{"raw_affiliation_string":"Affymax, Inc, Palo Alto, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108403081","display_name":"Krishna R. Polu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151439","display_name":"Affymax (United States)","ror":"https://ror.org/0505r1x13","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krishna R Polu","raw_affiliation_strings":["Affymax, Inc, Palo Alto, CA, USA","Affymax, Inc, Palo Alto, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affymax, Inc, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I4210151439"]},{"raw_affiliation_string":"Affymax, Inc, Palo Alto, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027701183","display_name":"Anne\u2010Marie Duli\u00e8ge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151439","display_name":"Affymax (United States)","ror":"https://ror.org/0505r1x13","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne-Marie Duliege","raw_affiliation_strings":["Affymax, Inc, Palo Alto, CA, USA","Affymax, Inc, Palo Alto, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affymax, Inc, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I4210151439"]},{"raw_affiliation_string":"Affymax, Inc, Palo Alto, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5073956335"],"corresponding_institution_ids":["https://openalex.org/I2803043754"],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":{"value":3090,"currency":"USD","value_usd":3090},"fwci":1.4311,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.82785397,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"13","issue":"1","first_page":"95","last_page":"95"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peginesatide","display_name":"peginesatide","score":1.0},{"id":"https://openalex.org/keywords/anemia-of-chronic-kidney-disease","display_name":"anemia of chronic kidney disease","score":0.7979999780654907},{"id":"https://openalex.org/keywords/hemodialysis-patients","display_name":"hemodialysis patients","score":0.7940000295639038},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.9279999732971191},{"id":"https://openalex.org/keywords/epoetin-alfa","display_name":"epoetin alfa","score":0.777999997138977},{"id":"https://openalex.org/keywords/dose-conversion","display_name":"dose conversion","score":0.7009999752044678},{"id":"https://openalex.org/keywords/hemoglobin-maintenance","display_name":"hemoglobin maintenance","score":0.7099999785423279},{"id":"https://openalex.org/keywords/once-monthly-dosing","display_name":"once-monthly dosing","score":0.8579999804496765},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.6980000138282776},{"id":"https://openalex.org/keywords/erythropoietin-receptor","display_name":"erythropoietin receptor","score":0.7059999704360962},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9390606880187988},{"id":"https://openalex.org/C54847362","wikidata":"https://www.wikidata.org/wiki/Q177635","display_name":"Nephrology","level":2,"score":0.8275357484817505},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.7149704098701477},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.6740996837615967},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5954039096832275},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.448635995388031}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006435","descriptor_name":"Renal Dialysis","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1186/1471-2369-13-95","doi":"https://doi.org/10.1186/1471-2369-13-95","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2369-13-95","pdf_url":"https://bmcnephrol.biomedcentral.com/counter/pdf/10.1186/1471-2369-13-95","source":{"id":"https://openalex.org/S172421378","display_name":"BMC Nephrology","issn_l":"1471-2369","issn":["1471-2369"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Nephrology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3511162","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3511162","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Nephrol","raw_type":"Text"},{"id":"pmid:22935486","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22935486","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC nephrology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:doaj.org/article:db5368aa5b7d4b8dbba005e05f7077c6","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/db5368aa5b7d4b8dbba005e05f7077c6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Nephrology, Vol 13, Iss 1, p 95 (2012)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1471-2369-13-95","doi":"https://doi.org/10.1186/1471-2369-13-95","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2369-13-95","pdf_url":"https://bmcnephrol.biomedcentral.com/counter/pdf/10.1186/1471-2369-13-95","source":{"id":"https://openalex.org/S172421378","display_name":"BMC Nephrology","issn_l":"1471-2369","issn":["1471-2369"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Nephrology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309659","display_name":"Henry Ford Health System","ror":"https://ror.org/02kwnkm68"},{"id":"https://openalex.org/F4320319305","display_name":"Satellite Healthcare","ror":"https://ror.org/054j4ex16"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2020051786.pdf","grobid_xml":"https://content.openalex.org/works/W2020051786.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1983849763","https://openalex.org/W1985653723","https://openalex.org/W1998943227","https://openalex.org/W2033803279","https://openalex.org/W2034437277","https://openalex.org/W2040029744","https://openalex.org/W2042920536","https://openalex.org/W2048489207","https://openalex.org/W2109214349","https://openalex.org/W2121071240","https://openalex.org/W2123851181","https://openalex.org/W2135454486","https://openalex.org/W2142343307","https://openalex.org/W2331665138","https://openalex.org/W2580449060","https://openalex.org/W2584947097","https://openalex.org/W3025393355","https://openalex.org/W4231161631"],"related_works":["https://openalex.org/W2028909058","https://openalex.org/W7100599409","https://openalex.org/W2131222899","https://openalex.org/W2331089096","https://openalex.org/W2109214349","https://openalex.org/W2071444329","https://openalex.org/W2146865720","https://openalex.org/W4233288745","https://openalex.org/W2321377008","https://openalex.org/W1986631113"],"abstract_inverted_index":{"BACKGROUND:":[0],"Peginesatide":[1,116],"is":[2,280],"a":[3,88,96,109,207],"peptide-based":[4],"erythropoiesis-stimulating":[5,111,217,257],"agent":[6],"that":[7,19,39,76,188,205,214,230,236],"was":[8,31,58,85,114,156,231,251],"designed":[9],"and":[10,103,137],"engineered":[11],"to":[12,32,74,120,146,183,267],"stimulate":[13],"specifically":[14],"the":[15,34,54,81,149,152,160,174,177,223,246,269],"erythropoietin":[16],"receptor":[17],"dimer":[18],"governs":[20],"erythropoiesis.":[21],"The":[22,260],"primary":[23],"objective":[24],"of":[25,46,56,68,132,151,162,170,176,249,255,262],"this":[26,244,263],"phase":[27,275],"2":[28],"dose-finding":[29],"study":[30,153,178,264],"determine":[33],"once-monthly":[35],"peginesatide":[36,57,82,140,199,250,279],"dosing":[37,270],"strategy":[38],"would":[40],"maintain":[41,121],"hemoglobin":[42,122,165,228],"within":[43,124,167],"\u00b11.0":[44,125,168],"g/dL":[45,126,169],"baseline":[47,171],"values":[48],"after":[49],"conversion":[50,93,101,192,210],"from":[51,127,179],"epoetin":[52,69,90],"alfa;":[53],"safety":[55,247],"evaluated":[59],"concurrently.":[60],"METHODS:":[61],"Chronic":[62],"hemodialysis":[63,283],"patients":[64,134,163],"on":[65,78,104],"stable":[66,198],"regimens":[67,271],"alfa":[70],"were":[71,118,135,265],"sequentially":[72],"assigned":[73],"cohorts":[75,204,213,235],"differed":[77],"(1)":[79],"how":[80],"starting":[83],"dose":[84,92,191,209],"determined":[86],"(using":[87],"single":[89,208],"alfa-to-peginesatide":[91],"ratio":[94],"or":[95,99,107],"tiered,":[97],"weight-based":[98],"absolute-dose":[100],"table)":[102],"(2)":[105],"whether":[106],"not":[108,221,238],"1-week":[110],"agent-free":[112,218],"interval":[113,219],"used.":[115],"doses":[117,200],"titrated":[119],"levels":[123,166,229],"baseline.":[128],"RESULTS:":[129],"A":[130],"total":[131],"164":[133],"enrolled":[136],"received":[138],"intravenous":[139],"every":[141],"4":[142],"weeks":[143],"for":[144],"up":[145],"6":[147],"doses;":[148],"duration":[150],"including":[154],"follow-up":[155],"\u226429":[157],"weeks.":[158],"Overall,":[159],"proportion":[161],"with":[164,253],"increased":[172],"over":[173],"course":[175],"39%":[180],"(Weeks":[181,185],"2-13)":[182],"54%":[184],"18-25).":[186],"Cohorts":[187],"used":[189,206,215,266,272],"tiered":[190],"tables":[193],"trended":[194],"towards":[195],"having":[196],"more":[197],"than":[201],"did":[202,220,237],"those":[203,234,254],"ratio.":[211],"Moreover,":[212],"an":[216,241],"have":[222],"substantial":[224],"initial":[225],"increase":[226],"in":[227,233,274,282],"seen":[232],"use":[239],"such":[240],"interval.":[242],"In":[243],"study,":[245],"profile":[248],"consistent":[252],"marketed":[256],"agents.":[258],"CONCLUSIONS:":[259],"results":[261],"guide":[268],"subsequently":[273],"3":[276],"studies.":[277],"Once-monthly":[278],"feasible":[281],"patients.":[284],"TRIAL":[285],"REGISTRATION:":[286],"ClinicalTrials.gov":[287],"registration:":[288],"NCT00228449.":[289]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}